chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram abnormal, Endotracheal intubation, Haemorrhage intracranial, Hypervolaemia
Clinical narrative: Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01.  Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Jugular vein distension, Laboratory test, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal abnormal
Clinical narrative: Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01.  Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mental disorder, Myocardial necrosis marker increased, Oedema peripheral, Pleural effusion, Pulseless electrical activity
Clinical narrative: Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01.  Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sepsis, Spinal cord infection, Staphylococcal bacteraemia, Tachycardia, Troponin increased
Clinical narrative: Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01.  Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unresponsive to stimuli, Viral cardiomyopathy, White blood cell count normal
Clinical narrative: Patient seen in ED at the Hospital. Patient presented to ED with worsening shortness of breath and hypoxia. Patient was hypoxic at home. Patient had recent admission with sepsis secondary to lumbar spine infection with MSSA bacteremia and intracranial hemorrhage discharged to rehab on IV cefazolin. Patient was initially tachycardic. Lactic acid 1.92, white blood cell count 9.01.  Noted to have elevated troponin. He appeared fluid overloaded with JVD and peripheral edema. BNP was elevated and chest x-ray appeared to show no focal infiltrates to suggest pneumonia. Cardiac enzymes were very mildly elevated. His EKG showed A. fib. He has no chest pain and no shortness of breath at rest. Chest xray with Rt pleural effusion. Patient was treated with Lasix. Patient was scheduled to have an MRI to further assess his infection and lumbar spine. This was performed in the emergency department and showed worsening of the fluid collection than previously noted. He had been on IV antibiotics with no acute surgical intervention, but the areas needed to be drained by interventional radiology. Patient was admitted for further management. Patient developed PEA arrest. No PE or significant rise in troponin level. Echocardiogram did show significant decrease of LVE F, from 40% to 20%. Suspect viral cardiomyopathy. He was intubated and started on Decadron protocol. Mentally, he was unresponsive off sedation. Head imaging with MRI was negative for acute process. Suspected anoxic brain injury. Treatment was continued but no meaningful mental recovery. POA elected to pursue comfort/hospice care. Discharge to inpatient hospice service 6/6/22 Pt was on comfort cares and transitioned to in hospital hospice. He time of death was 1610.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Muscular weakness
Clinical narrative: Patient contacted Health Center 6/11/22 stating 1 hour after administration severe chest pain, sob, muscle weakness, severe headache. Reports going to Emergency Room.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: NA;  2nd dose 0.5 cc moderna; previous 2nd invalid received pediatric Orange top Pfizer.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Diarrhoea, Pyrexia, Rash, Streptococcus test
Clinical narrative: Fever on day of vaccination, tmax 102 Diarrhea following 2 days 2 days later whole body rash no swelling
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Patient given a 3 dose of the Shingrix Vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient was not eligible for a fourth dose of Moderna (second booster dose) because she is not over 50 years old and is not immunocompromised.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: transferred to medical facility from hospital 6/17/22, routine covid test collected as part of admission process- tested positive on binax rapid antigen test 6/17/22  had previous negative Abbott molecular test at hospital 6/16/22
Age: 62.0
Sex: F
Vaccine: COVID19, TDAP, VARZOS
Symptoms: Headache, Limb discomfort, Lymphadenopathy
Clinical narrative: Patient presented to pharmacy this morning around 930am stating she woke up on day 2 with her lymph node under her left arm totally swollen and uncomfortable along with a headache in the back of her head on the right side.  She said the swelling had continued into today along with the headache.  The swelling is on the side where the covid shot was given...NOT the other two shots.  I recommended she go to her dr or urgent care to follow up but she is visiting  and has no insurance here and didn't want to go in.  She wanted to know if lymphadenopathy was an adverse effect of the shot.  It shows less than 2% however I still recommended she go be checked out due to her history and headache.  She said she had taken Motrin and/or APAP for headache.  Told her if she won't go in then if symptoms worsen or she gets fever she definitely needs to go in.  She wished to just monitor at this time due to insurance being in another country and she is supposed to be heading back and she can see her Dr. at that time.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pt scheduled  for a Moderna booster shot. Pt had previously had 2 full doses of Moderna vaccine on 3/9/21 & 2/9/21. Pt had a booster dose on 11/5/21. Pt's father self reported pt was immunocompromised. Once immunocompromise status was entered into the pt's  chart the dose recommendation changed from no dose recommended to FULL dose due. However, booster dose was administered.   Education provide to father & pt that full dose should have been given based on report of immunocompromise. Father declined for pt to receive any additional dosing.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: developed sore throat, stuffy nose on 6/17/22, tested positive on home covid test
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: 101.8 fever, mild nausea, muscle aches, and moderate headache persisting at present through 25 hours post dose
Age: 1.75
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Crying, Screaming, Urticaria
Clinical narrative: Patient was unusually screaming and crying the night after the vaccination. This followed by appearance of "hives" on both cheeks, back, and buttocks. Resolved after intake of Benadryl.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Feeling abnormal, Headache, Hyposmia
Clinical narrative: Breakthrough COVID Case: My symptoms were cough, low fever, nasal congestion, headache, brain fog, and sore throat. I took an at home test after I got symptoms and it was negative. I took another one the next day and it was positive. I also got a PCR test after that and it was positive. I called my doctor and she prescribed Paxlovid. This is about day seven now. My sense of smell diminished a couple days ago, but overall fairly mild symptoms...like a bad cold.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Breakthrough COVID Case: My symptoms were cough, low fever, nasal congestion, headache, brain fog, and sore throat. I took an at home test after I got symptoms and it was negative. I took another one the next day and it was positive. I also got a PCR test after that and it was positive. I called my doctor and she prescribed Paxlovid. This is about day seven now. My sense of smell diminished a couple days ago, but overall fairly mild symptoms...like a bad cold.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID Case: My symptoms were cough, low fever, nasal congestion, headache, brain fog, and sore throat. I took an at home test after I got symptoms and it was negative. I took another one the next day and it was positive. I also got a PCR test after that and it was positive. I called my doctor and she prescribed Paxlovid. This is about day seven now. My sense of smell diminished a couple days ago, but overall fairly mild symptoms...like a bad cold.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Muscle rigidity, Tonic clonic movements, Unresponsive to stimuli
Clinical narrative: Pt recieved her vaccine and within a couple of minutes became unresponsive, full body rigidity, followed by tonic clonic movenents involving her body lasting for over a minute.  BP was 70/ unable to determine. O2 sat was 97%, Pulse was 67. Transported to ER via ambulance. Recieved her first meningococcal vaccine 05/23/2017
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Amniocentesis normal, Cytogenetic analysis normal, Exposure during pregnancy, Foetal death, Hydrops foetalis
Clinical narrative: Received third booster on 11/19/21. Appx 3 weeks pregnant at the time. Developed non-immune fetal hydrops early in pregnancy. Ultimately with severe hydrops, leading to fetal loss at 17 weeks pregnancy.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Prenatal screening test, Ultrasound antenatal screen normal
Clinical narrative: Received third booster on 11/19/21. Appx 3 weeks pregnant at the time. Developed non-immune fetal hydrops early in pregnancy. Ultimately with severe hydrops, leading to fetal loss at 17 weeks pregnancy.
Age: 16.0
Sex: F
Vaccine: COVID19, MNQ
Symptoms: Extra dose administered
Clinical narrative: Patient was not eligible for 4th dose of COVID vaccine. Patient is not immunocompromised. 1st dose- 5/14/21 2nd dose- 6/4/21 3rd dose- 1/7/22
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Condition aggravated, Cough, Dysphagia
Clinical narrative: I started to feeling a little run down and a little flu like, my stomach was uneasy. On Monday I was coughing severely, fever of 101F, GI pain, severe flu symptoms, I took a home COVID 19 test that came up negative. On Tuesday it came up positive, I could not swallow so I could not eat or drink anything. I called my doctor on Wednesday, she prescribed me PAXLOVID, after my first dose I started feeling better.  By the following Wednesday I was able to go back to work but it took a month before I felt 100 percent myself. I felt fatigue that whole month. While I had COVID 19 all my underlying conditions got worse.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeding disorder, Feeling abnormal, Fibromyalgia, Fluid intake reduced
Clinical narrative: I started to feeling a little run down and a little flu like, my stomach was uneasy. On Monday I was coughing severely, fever of 101F, GI pain, severe flu symptoms, I took a home COVID 19 test that came up negative. On Tuesday it came up positive, I could not swallow so I could not eat or drink anything. I called my doctor on Wednesday, she prescribed me PAXLOVID, after my first dose I started feeling better.  By the following Wednesday I was able to go back to work but it took a month before I felt 100 percent myself. I felt fatigue that whole month. While I had COVID 19 all my underlying conditions got worse.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Gastrointestinal pain, Gastrooesophageal reflux disease, Impaired work ability, Influenza like illness
Clinical narrative: I started to feeling a little run down and a little flu like, my stomach was uneasy. On Monday I was coughing severely, fever of 101F, GI pain, severe flu symptoms, I took a home COVID 19 test that came up negative. On Tuesday it came up positive, I could not swallow so I could not eat or drink anything. I called my doctor on Wednesday, she prescribed me PAXLOVID, after my first dose I started feeling better.  By the following Wednesday I was able to go back to work but it took a month before I felt 100 percent myself. I felt fatigue that whole month. While I had COVID 19 all my underlying conditions got worse.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: I started to feeling a little run down and a little flu like, my stomach was uneasy. On Monday I was coughing severely, fever of 101F, GI pain, severe flu symptoms, I took a home COVID 19 test that came up negative. On Tuesday it came up positive, I could not swallow so I could not eat or drink anything. I called my doctor on Wednesday, she prescribed me PAXLOVID, after my first dose I started feeling better.  By the following Wednesday I was able to go back to work but it took a month before I felt 100 percent myself. I felt fatigue that whole month. While I had COVID 19 all my underlying conditions got worse.
Age: 13.0
Sex: F
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: LPN inadvertently administered Menactra vaccine that was 4 days past expiration, Pt showed no obvious sings of ASE r/t expired dose of vaccine, LPN  reported inadvertent administration to provider right away, LPN called manufacture and manufacture stated that There is no contraindications from the CDC regarding expired vaccine at this time, Manufacture stated that the pt will need to repeat vaccine as soon as possible, LPN called and spoke with Pt legal guardian and explained what had happened, Pt legal guardian stated that the pt appeared to be normal and had no complaints regarding expired vaccine.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Face injury, Head injury, Loss of consciousness, Syncope
Clinical narrative: <5min after receiving pfizer covid vaccine, he had syncope. unconscious for <10 sec, HR initially 50, BP 97/58, rapidly improved to HR in 70s-80s. hit R frontal head and under R chin with no lacerations. complained intermittently of dizziness. discharged home from clinic 50 minutes later. called back 1.5 hrs after event stating he had vomited twice, so was sent to ER, where exam was similarly normal and no testing/imaging was done.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: <5min after receiving pfizer covid vaccine, he had syncope. unconscious for <10 sec, HR initially 50, BP 97/58, rapidly improved to HR in 70s-80s. hit R frontal head and under R chin with no lacerations. complained intermittently of dizziness. discharged home from clinic 50 minutes later. called back 1.5 hrs after event stating he had vomited twice, so was sent to ER, where exam was similarly normal and no testing/imaging was done.
Age: 62.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Crying, Hypersensitivity, Oropharyngeal pain
Clinical narrative: Reports a delayed allergic reaction at home, Patient called clinic hours later, patient is in distress, crying, due to allergic reaction c/o throat pain
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fear, Impaired driving ability, Refusal of vaccination, Vertigo
Clinical narrative: Client 53 y/o, female, , presented as a walk in to the vaccination site on 06/17/2022. The client appears alert and oriented x4, no visible s/ sx of illness, no symptoms nor allergies reported, cooperative, friendly, talkative and well dressed. Client reported to have experienced severe dizziness (lightheaded) after around ~15 minutes from her discharge from the clinic after her 2nd shot of Pfizer lot # FD0809 given on 08/28/2021. She experienced sudden dizziness while drive home after discharged from clinic (aprox. ~45-60 minutes from the given Pfizer 2nd shot). She recalls that she felt scared while driving home and was able to make it  home safely. Her son, an EMT, help her get into the house and called 911 due to her dizziness "it felt like the room was spinning".  Client mentioned that she refused hospitalization. Client reports a medical hx of: Allergies, asthma, TIA (01/1999), Myocarcinoma (2003), migranes, high cholesterol, Surgeries: sinus, tonsillectomy, tumor. Current Rx.: EpiPen, Buproprion, Statins, Inhalers: Fluvent and albuterol, Claritin.  RN consulted site's supervisor RN. RN  submitted a medical consult via text to Dr. at 12:54 pm on 6/17/2022 to inquire on approval to proceed with COVID Booster. Dr. approved at 12:55 pm to proceed with the booster shot for the client. RN informed the client and vaccinator of the approval immediately. The patient  seemed hesitant and reported some anxiety. RN offered to give client extra time to ask questions, read paperwork on vaccine information , reactions and side effects, and suggested to consult with her PCP.  The vaccinator RN: proceeded to continue with the intake questionnaire, gather paperwork, educated client and provided information regarding side effects, allergic reactions, and when to seek medical care or 911 and to register with V-Safe. prepare client for administration. The client was given time to read the CDC Vaccine information.  The client decided to leave the clinic and to consult her PCP before her 1st booster and walked out the clinic at 13:20 showing no s/sx of acute distress, alert and orientedrnted x4, talkative, no reporting any s/sx, and smiling.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Joint noise, Pain, Sleep disorder
Clinical narrative: The shot was given very high in my shoulder and was painful immediately as it was being given.  The pain radiated out in a four inch circle as it was being given.  This was my second Covid vaccine shot.  The pain in my shoulder continued to get worse as the weeks went by, and it was very painful at night when trying to sleep, and also doing ordinary household chores.  I went to doctor and she prescribed physical therapy and took an x-ray.  My shoulder joint continued to feel very bad and I was also experiencing joint pain, clicking and popping in my right hand, knees and feet.  The most pain was in my shoulder joint. I am going yto physical therapy and doing the prescribed excercises daily.  Three months have gone by and my shoulder joint still hurts, and my other joints hurt, and I have never experienced this type of pain before.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: The shot was given very high in my shoulder and was painful immediately as it was being given.  The pain radiated out in a four inch circle as it was being given.  This was my second Covid vaccine shot.  The pain in my shoulder continued to get worse as the weeks went by, and it was very painful at night when trying to sleep, and also doing ordinary household chores.  I went to doctor and she prescribed physical therapy and took an x-ray.  My shoulder joint continued to feel very bad and I was also experiencing joint pain, clicking and popping in my right hand, knees and feet.  The most pain was in my shoulder joint. I am going yto physical therapy and doing the prescribed excercises daily.  Three months have gone by and my shoulder joint still hurts, and my other joints hurt, and I have never experienced this type of pain before.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test abnormal, Dizziness, Lethargy, Vitamin B12 deficiency, Vitamin D deficiency
Clinical narrative: Lethargy and dizziness lasting several months; Took weekly vitamin B12 shots followed by monthly shots and vitamin D3 supplements; Symptoms gradually improved, still not completely gone.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal faeces, Diarrhoea, Dizziness, Feeling abnormal, Hyperhidrosis
Clinical narrative: At the time of the shot, it was extremely painful- unlike the previous ones.  The technician said he must have hit a nerve.  I felt very bad the next morning to the point of almost feeling faint, broke out in a sweat.   Within about 5 days of the 4th shot, I began having a change in stools.  They became smaller, looser, sometimes do not hold together.  On occasion- diarrhea. This is a very different status from normal for me.  A return to pre-last booster has not occurred yet.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Laboratory test, Neuralgia
Clinical narrative: At the time of the shot, it was extremely painful- unlike the previous ones.  The technician said he must have hit a nerve.  I felt very bad the next morning to the point of almost feeling faint, broke out in a sweat.   Within about 5 days of the 4th shot, I began having a change in stools.  They became smaller, looser, sometimes do not hold together.  On occasion- diarrhea. This is a very different status from normal for me.  A return to pre-last booster has not occurred yet.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Early vaccine administration, 2nd dose Shingrix Vaccine administered on the 32nd day.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned,  took the following steps: ? Covid-19 Response Unit Pharmacists contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  o A county medical director was contacted and based on this information from Moderna, no re-vaccination is needed.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Have not heard back from patient's guardian yet.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Covid-19 Response Unit Pharmacists contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  o A county medical director was contacted and based on this information from Moderna, no re-vaccination is needed.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test, Chills, Computerised tomogram, Diplopia, Feeling hot
Clinical narrative: migraine , double vison, stiff neck. next day chills, extremely warm and headache. Inj shot of toradol, Inj Reglan. Inj Benadryl.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Migraine, Musculoskeletal stiffness
Clinical narrative: migraine , double vison, stiff neck. next day chills, extremely warm and headache. Inj shot of toradol, Inj Reglan. Inj Benadryl.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Pain
Clinical narrative: pain, limited range of motion right shoulder
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19, COVID-19 pneumonia, Condition aggravated
Clinical narrative: Patient received Moderna COVID vaccine on 2/20/21 (lot # 012M20A), 3/18/21 (lot # 045A21A), 9/14/21(lot # 004F21A), and 4/20/22 (lot # 002M1A). On 6/14/22, patient admitted to our inpatient facility (med/surg. unit) with acute hypoxemic respiratory failure due to COVID-19 pneumonia, atrial fibrillation with rapid ventricular response, and ESRD on HD. Patient was discharged home on 6/16/22.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: End stage renal disease, Haemodialysis, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient received Moderna COVID vaccine on 2/20/21 (lot # 012M20A), 3/18/21 (lot # 045A21A), 9/14/21(lot # 004F21A), and 4/20/22 (lot # 002M1A). On 6/14/22, patient admitted to our inpatient facility (med/surg. unit) with acute hypoxemic respiratory failure due to COVID-19 pneumonia, atrial fibrillation with rapid ventricular response, and ESRD on HD. Patient was discharged home on 6/16/22.
Age: 56.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Erythema, Feeling hot, Headache, Inflammation, Malaise
Clinical narrative: It started with a general malaise and then my arm started to hurt and I could not move it, I was one night and all the next time with temperature ranging between 100.4 and 99.7, pain throughout the body, headache and in the arm I found a red spot and very hot and inflamed, a feeling of extreme tiredness.
Age: 56.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Mobility decreased, Pain, Pain in extremity
Clinical narrative: It started with a general malaise and then my arm started to hurt and I could not move it, I was one night and all the next time with temperature ranging between 100.4 and 99.7, pain throughout the body, headache and in the arm I found a red spot and very hot and inflamed, a feeling of extreme tiredness.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Antiplatelet therapy, Aspartate aminotransferase increased, Blood cholesterol normal, Blood triglycerides normal
Clinical narrative: On 6/9/2022 pt developed sudden chest pain. This was initially lower sub-sternal chest pain described as 5/10. Chest pain then became sharper and more severe in nature prompting a call to EMS. Pt was treated with aspirin en route to ED. Pain subsided within the next hour. There was no radiating pain, shortness of breath, nausea or diaphoresis. Pt had never experienced anything similar. EKG with without ischemic changes. Troponin at 3 hours was 13.9. Medication included ASA 324 mg, Plavix 75 mg and heparin bolus/drip. Pt transferred to higher level of care for admission per Cardiology where she underwent an ECHO and heart catheterization which demonstrated dissected coronary artery.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Catheterisation cardiac abnormal, Chest pain, Coronary artery dissection, Echocardiogram abnormal, Electrocardiogram normal
Clinical narrative: On 6/9/2022 pt developed sudden chest pain. This was initially lower sub-sternal chest pain described as 5/10. Chest pain then became sharper and more severe in nature prompting a call to EMS. Pt was treated with aspirin en route to ED. Pain subsided within the next hour. There was no radiating pain, shortness of breath, nausea or diaphoresis. Pt had never experienced anything similar. EKG with without ischemic changes. Troponin at 3 hours was 13.9. Medication included ASA 324 mg, Plavix 75 mg and heparin bolus/drip. Pt transferred to higher level of care for admission per Cardiology where she underwent an ECHO and heart catheterization which demonstrated dissected coronary artery.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Glycosylated haemoglobin normal, High density lipoprotein decreased, Low density lipoprotein normal, Total cholesterol/HDL ratio
Clinical narrative: On 6/9/2022 pt developed sudden chest pain. This was initially lower sub-sternal chest pain described as 5/10. Chest pain then became sharper and more severe in nature prompting a call to EMS. Pt was treated with aspirin en route to ED. Pain subsided within the next hour. There was no radiating pain, shortness of breath, nausea or diaphoresis. Pt had never experienced anything similar. EKG with without ischemic changes. Troponin at 3 hours was 13.9. Medication included ASA 324 mg, Plavix 75 mg and heparin bolus/drip. Pt transferred to higher level of care for admission per Cardiology where she underwent an ECHO and heart catheterization which demonstrated dissected coronary artery.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin
Clinical narrative: On 6/9/2022 pt developed sudden chest pain. This was initially lower sub-sternal chest pain described as 5/10. Chest pain then became sharper and more severe in nature prompting a call to EMS. Pt was treated with aspirin en route to ED. Pain subsided within the next hour. There was no radiating pain, shortness of breath, nausea or diaphoresis. Pt had never experienced anything similar. EKG with without ischemic changes. Troponin at 3 hours was 13.9. Medication included ASA 324 mg, Plavix 75 mg and heparin bolus/drip. Pt transferred to higher level of care for admission per Cardiology where she underwent an ECHO and heart catheterization which demonstrated dissected coronary artery.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: redness and swelling at injection site for 2 days
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Hypertension, Malaise, Palpitations
Clinical narrative: Pt had High Blood Pressure, palpitation, and felt sick after moderna shot
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 83.0
Sex: M
Vaccine: PNC20
Symptoms: Dizziness, Fall, Skin laceration
Clinical narrative: Patient's daughter called at around 7:15pm to inquire which vaccine patient had received.  She claimed patient had become dizzy.  He leaned over to pick something up and fell down, receiving a gash on his arm.  She claimed that he had already received a pneumonia vaccine in the past and wanted to know if this might have been a factor precipitating patient dizziness. I explained that patient had not indicated to us at the time of signing vaccine consent form that he had received any previous pneumonia vaccine.  Explained to patient's daughter that depending on which he had received in the past, the vaccine given today would have been recommended.  She was not certain which he had received in the past.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The morning after the vaccine was given the patient experienced a larger than expected adverse effect profile and noticed he was given a full 0.5ml dose. He then realized he should have received a booster dose and reported his symptoms to the pharmacy.   His first two doses of the Covid vaccine were given at another location and the patient requested and reported needing a  "second" dose. This was confirmed at the time of administration and according to all information that was presented we thought the patient was receiving the correct dose in the series.   As we discussed his experience he acknowledged we had less than adequate communication. We checked in on him on 06/17 and he reported feeling 99% with resolution of nealry all vaccine related side effects.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 42.0
Sex: F
Vaccine: HPV9
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Pt presented to ER with complaints of SOB and high fevers. Evaluation noting high fever and hypoxia on RA improving with supplemental oxygen 2-3L. Lab work up noting creatinine of 5.8. CXR with patchy bilateral airspace disease. Subsequently admitted with consults to ID and nephrology. IVF ordered with improvement.  Discharge diagnosis was COVID 19 pneumonia positive test on 10/3/21; s/p rocephin/doxy, ID following  Acute hypoxic respiratory failure second to above; requiring supplemental oxygen 3LPM; on decadron
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Lung disorder, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pt presented to ER with complaints of SOB and high fevers. Evaluation noting high fever and hypoxia on RA improving with supplemental oxygen 2-3L. Lab work up noting creatinine of 5.8. CXR with patchy bilateral airspace disease. Subsequently admitted with consults to ID and nephrology. IVF ordered with improvement.  Discharge diagnosis was COVID 19 pneumonia positive test on 10/3/21; s/p rocephin/doxy, ID following  Acute hypoxic respiratory failure second to above; requiring supplemental oxygen 3LPM; on decadron
Age: 12.0
Sex: M
Vaccine: DTAP, HPV9, MNQ
Symptoms: Asthenia, Cyanosis, Loss of consciousness, Pallor
Clinical narrative: Approximately 5 minutes after last vaccine given, Patient went pale, lips turned blue and then he lost consciousness. He lost consciousness for a couple of minutes and within 10 minutes was alert but still feeling weak. Withing 30 minutes he was acting normal.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Client was present in the clinic on 6/15/2022 for her booster dose of adult Pfizer. She received the pediatric-formulation of Pfizer (lot number FL0007) to her LD. The client and her guardian were made aware and the physician was called. He recommended to follow the CDC guidance for such situations; the client may receive the adult formulation of Pfizer 21 days from the date of this vaccination if she and/or her guardian choose. The guardian was provided education on the occurrence, risks/benefits of revaccination, side effects and how to treat them. The guardian verbalized understanding.  The vaccinator, MA reported that the incident stemmed from a mis-communication. Another staff member, RN, reported that there were ?3 peds and 1 adult? in the group to be vaccinated, meaning that there was 1 child who was 12 years old and due to receive the adult formulation of the vaccine. The vaccinator took this to mean non-minor adult and thought that the 12 year old client was meant to receive the pediatric vaccine.   All staff were educated on procedures designed to reduce the risk of providing inappropriate vaccination types: ? Use the age of the client when announcing clients for vaccination and escorting them to the vaccination area from the registration area.  ? Verify the client?s name, DOB and vaccine type verbally with the client and/or scribe (staff member completing documentation) ? Verify the client?s age as displayed in the computer, ensure that it is appropriate for the type of vaccine to be delivered.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Lethargy
Clinical narrative: shot given 6/14/22 inject site little red; 6/15/22 felt lethargic no fever; 6/16/22 felt ok injection site still red; 6/17/22 redness on arm spreading to elbow, not painful; pt went to urgent care and prescribed antibiotic for 7 days
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Pfizer age 5y to <12 was given to patient that was not diluted. She was given 0.2 mL non diluted Pfizer vaccine.  At this time patient has had no adverse reactions.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arrhythmia, Brain natriuretic peptide, Dizziness, Dyspnoea, Echocardiogram
Clinical narrative: Sudden onset heart palpitations, arrhythmia, shortness of breath, lightheadedness
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory, Full blood count, Palpitations, Thyroid function test
Clinical narrative: Sudden onset heart palpitations, arrhythmia, shortness of breath, lightheadedness
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 3/9/21 and 4/5/21. On 6/15/22, patient admitted to our inpatient facility (med/surg unit) with acute on chronic respiratory failure in setting of COVID 19 infection and COPD exacerbation. As of today (6/17/22), patient is still admitted in the med/surg  unit.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Lip discolouration
Clinical narrative: PATIENT FELL WITHIN A 1 MINUTE AFTER RECEIVING THE VACCINE  WHEN TRYING TO GET OUT OF THE IMMUNIZATION ROOM TOWARDS THE POST VACCINATION WAITING AREA.  SHE GOT UP RIGHT AWAY AND WAS RESPONSIVE SAYING SHE IS DOING ALRIGHT. WE STILL CALLED 911 AND THEY MONITORED (VITALS)HER FOR SOMETIME. HER LIPS TURNED DARKER BUT SHE WAS TALKING TO EVERYONE AND RESPONDING. PARAMEDICS SAID SHE WAS DOING ALRIGHT AND DOES NOT NEED TO BE TAKEN TO THE HOSPITAL FOR NOW. THEY  SUGGESTED HER TO SEEK MEDICAL HELP IF SHE REALIZE ANYTHING IS ABNORMAL.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Administration site pain, Fatigue, Influenza like illness, Injection site erythema, Injection site induration
Clinical narrative: esp. painful administration 1 day (expected) flu-like symptoms (similar to shot#1) and total exhaustion 5 days of  2-3 inch hot, red, hard, iching injection site (NEVER experienced this before with ANY shot) Today, day 8, the site is no longer hot or warm, but there?s still a round 3-inch red mark covering the injection area. Forgive my language, but this is a bitch of a vaccine
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site warmth
Clinical narrative: esp. painful administration 1 day (expected) flu-like symptoms (similar to shot#1) and total exhaustion 5 days of  2-3 inch hot, red, hard, iching injection site (NEVER experienced this before with ANY shot) Today, day 8, the site is no longer hot or warm, but there?s still a round 3-inch red mark covering the injection area. Forgive my language, but this is a bitch of a vaccine
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fall, Hypotension, Labile blood pressure
Clinical narrative: About 18 hrs after the injection trying to get out of the chair she fell . She felt weak all over.  Paramedics arrived and put her on the bed . It took several hrs to regain strength so that she could get up. Was not taken to ED to no specific treatment other then resting. Visit to physician to discuss further was not until 6/17/22. Of note she has labile BP and sometimes very low with weakness but low BP was not reported as part of this event. Reports also feeling generally weak the day after her second Moderna vaccine also with a fall but this was a more significant event. Was okay after the 1st and 3rd vaccinations. All were Moderna.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Malaise, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: May 5, 2022 felt ill sore throat, runny nose. Used home covid test kit tested positive contacted my Primary Care doctor who prescribed Paxlovid for 5 days.
Age: 66.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Dysgeusia
Clinical narrative: Strong metallic taste.  Started 5 days after vaccination. Has not resolved yet,  10 days after vaccination.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Euphoric mood, Fatigue, Impaired work ability, Lethargy
Clinical narrative: High fever, lethargy, euphoria/light headed, dizzy, extreme vertigo, massive migraine, extreme fatigue. Missed the entire week of work due to symptoms from shot.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia, Vertigo
Clinical narrative: High fever, lethargy, euphoria/light headed, dizzy, extreme vertigo, massive migraine, extreme fatigue. Missed the entire week of work due to symptoms from shot.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring, Electrocardiogram, Palpitations
Clinical narrative: 16 hours after receiving booster heart racing to 180 and uncontrollable palpitations
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Confusional state, Dizziness, Dysstasia
Clinical narrative: 1. Electric shocks up back of neck into head an hour after (with all three).  2. Lymphatic fluid swelling in left armpit within 12 hours, after 24  hours the swelling was huge and watery and had moved down. After 36 hours it looked like a large implant on the side of his torso.  3. Main event was upon waking on May 1st: woke up with the swollen area being sore and stretched it out. Got up to start the day and got lightheaded, sudden heart palpitations, seeing spots, so he got on his knees then passed out and fell to floor. Spouse then witnessed a full TONIC seizure, starting with his pupils dilating then rolling backwards into his head, entire body went rigid for 25-30 seconds while letting out a loud scream/howl, then going limp and breathing stopped for about three seconds. He then started panting and sweating profusely. He was non-responsive and could not move or speak. Was gaining more speech by the time paramedics arrived but was very confused and tired. Could not stand or walk on his own. Was transported by ambulance to nearest hospital emergency room.